title: Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.
abstract: To prevent complications that might follow an infection with varicella-zoster virus (VZV), the live attenuated Oka strain (V-Oka) is administered to children in many developed countries. Three vaccine brands (Varivax from Sanofi Pasteur MSD; Varilrix and Priorix-Tetra, both from Glaxo-Smith-Kline) are licensed in Germany and have been associated with both different degrees of vaccine effectiveness and adverse effects. To identify genetic variants in the vaccines that might contribute to rash-associated syndromes, single nucleotide polymorphism (SNP) profiles of variants from the three vaccines and rash-associated vaccine-type VZV from German vaccinees were quantitatively compared by PCR-based pyrosequencing (PSQ). The Varivax vaccine contained an estimated 3-fold higher diversity of VZV variants, with 20% more wild-type (wt) SNPs than Varilrix and Priorix-Tetra. These minor VZV variants in the vaccines were identified by analyzing cloned full-length open reading frame (ORF) orf62 sequences by chain termination sequencing and PSQ. Some of these sequences amplified from vaccine VZV were very similar or identical to those of the rash-associated vaccine-type VZV from vaccinees and were almost exclusively detected in Varivax. Therefore, minorities of rash-associated VZV variants are present in varicella vaccine formulations, and it can be concluded that the analysis of a core set of four SNPs is required as a minimum for a firm diagnostic differentiation of vaccine-type VZV from wt VZV.
authors.affiliation: Division of Viral Infections, Robert Koch Institute, D-13353 Berlin, Germany.
authors.forename: Sonja
authors.initials: S
authors.lastname: Thiele
authors.forename: Aljona
authors.initials: A
authors.lastname: Borschewski
authors.forename: Judit
authors.initials: J
authors.lastname: Küchler
authors.forename: Marc
authors.initials: M
authors.lastname: Bieberbach
authors.forename: Sebastian
authors.initials: S
authors.lastname: Voigt
authors.forename: Bernhard
authors.initials: B
authors.lastname: Ehlers
mesh_terms: D000818:Animals; D019433:Chickenpox Vaccine / Q000009:adverse effects*; D002648:Child; D004279:DNA, Viral / Q000235:genetics; D005076:Exanthema / Q000209:etiology / Q000821:virology; D014645:Herpesvirus 3, Human / Q000235:genetics*; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D017422:Sequence Analysis, DNA; D012871:Skin Diseases / Q000209:etiology / Q000821:virology*
chemical_list: D019433:Chickenpox Vaccine; D004279:DNA, Viral